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Previewset al., 2012; Wong et al., 2012). Both Hoy-
ler et al. (2012) and Mjosberg et al. (2012)
showed that the expression of RORa is
not limited to ILC2, thus raising an inter-
esting question about the cell-intrinsic
role of RORa in ILC2. The development
and characterization of RORa mice with
ILC-specific deletion will help elucidate
the role of RORa in the future. Although
it was shown that RORA transcription is
not regulated by GATA-3 (Mjosberg
et al., 2012), it remains to be determined
whether RORa works in parallel to inter-
play with GATA-3 (e.g., by protein-protein
interaction), thereby promoting ILC2
development and function.
ILCs share a striking similarity to Th
cells in effector cytokine production.
Coevolution of two systems may be a
fail-safe mechanism to implement redun-
dancy in host immunity against certain
infections especially at the mucosal sur-
faces. Active cross-regulation between
individual ILCs and Th cells may also be
present in the host. Recent data suggest
that Th cells can display significant plas-ticity in certain conditions (e.g., during
infection and inflammation). It remains to
be determined whether this plasticity is
also associated with ILCs. Collectively,
the two papers published in the issue
shed novel light on the ILC biology and
demonstrate that ILC2 and Th2 cells
share the same master transcriptional
regulator GATA-3.REFERENCES
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In this issue of Immunity, Zhu et al. (2012) report amouse reporter strain for the transcription factor T-bet. This
reagent provides for the resolution of some longstanding issues in T helper cell development.A reagent reported in this issue of
Immunity sheds new light on some long-
standing and unresolved issues in T
helper (Th) cell development. Dr. William
E. Paul’s group describes the generation
and analysis of a green fluorescent pro-
tein reporter for the ‘master’ transcription
factor T-bet (Tbx21). T-bet is critical for
development of the Th1 cells that
generate the pleiotropic cytokine inter-
feron-g (IFN-g) needed in defense against
many intracellular pathogens. Although
a major role of T-bet in Th1 cell differenti-
ation has been appreciated for a decade,and although the initiating factors that
trigger Th1 cell development have been
appreciated for nearly two decades,
important issues have remained unre-
solved. Certain gaps, stemming more
from experiments that were never done
rather than unresolved experimental dis-
crepancies, have persisted as loose
threads left behind as people have moved
on to other topics. Fortunately, Dr. Paul,
who has worked in this area from its
beginning, has remained centrally fo-
cused on these gaps and now addresses
several longstanding issues by using anewly generated T-bet-ZsGreen reporter
mouse.
After the discovery of distinct CD4+
T cell effector subsets—from an in vitro
examination of T cell clones—the next
question was whether and how these
subsets developed in vivo in a normal
physiologic setting. The first physiologic
trigger was described for Th1 cell differ-
entiation; this trigger was the induction
of the cytokine IL-12 by Listeria monocy-
togenes from macrophages and dendritic
cells (Hsieh et al., 1993). Later, the tran-
scription factor STAT4 was found to be, October 19, 2012 ª2012 Elsevier Inc. 591
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Previewsactivated specifically by IL-12 in T cells
and to be involved in Th1 cell develop-
ment (Kaplan et al., 1996). A symmetrical
model for Th2 differentiation evolved for
IL-4-activating STAT6 in T cells, although
for quite some time it was unclear as to
what was the relevant stimulus to induce
IL-4 in this side of the cascade. After this
phase came two transformative discov-
eries: GATA3 was discovered as the tran-
scription factor that was induced in Th2
cells and that drove the production of
IL-4 and other Th2-cell cytokines (Zheng
and Flavell, 1997), and on the flip-side,
T-bet was identified as the Th1-cell-
expressed factor driving IFN-g produc-
tion and Th1 differentiation (Szabo et al.,
2000).
Since then, questions have centered on
how T-bet and GATA3 expression them-
selves are regulated and how T cells
manifest either a stable or "flexible"
pattern of gene expression. Newly de-
rived Th2 cells resisted redirection toward
the Th1 cell pathway not only by extin-
guishing IL-12 receptor expression but
also by a feed-forward pathway in which
GATA3 activates its own transcription
(Ouyang et al., 2000). The experimental
demonstration of ‘‘GATA3 autoactivation’’
relied on the ability of retroviral GATA3
overexpression to induce endogenous
GATA3 expression, even under Th1-cell-
polarizing conditions, upon neutralization
of IL-4, and in STAT6-deficient cells, to
exclude possible induction by Th2-cell-
related factors themselves. Thus, regard-
less of what first induced GATA3, a
nascent Th2 cell would tend to maintain
GATA3 and so remain a stabile Th2.
Certain questions relating to the regula-
tion of GATA3 have never been answered.
For example, two promoters drive GATA3
expression in T cells. Ideal analysis might
have utilized distinct reporters from each
promoter, but these have not material-
ized, and this area has progressed little.
Important and long-unresolved ques-
tions also existed regarding T-bet regula-
tion. The initial report identifying T-bet
(Szabo et al., 2000) suggested that IL-12
increased T-bet’s expression, which was
reduced in T cells lacking STAT4. This
suggestion argued that IL-12 activates
STAT4, which induces T-bet, which
drives IFN-g and Th1 cell development.
This scenario was consistent with earlier
work in which Th1 cell development did
not require IFN-g when IL-12 was pro-592 Immunity 37, October 19, 2012 ª2012 Elvided and with the fact that IFN-g was
unable to drive Th1 cell development by
itself (Hsieh et al., 1993). However, a
different model was put forth in a subse-
quent study (Mullen et al., 2001). That
study observed Th1 cell development in
STAT4-deficient T cells and argued that
T-bet acted to specify Th1 cell effector
fate and to remodel chromatin in the Ifng
locus without assistance from IL-12 or
STAT4 (Mullen et al., 2001). These conclu-
sions were based on observation of IFN-g
production measured by intracellular
staining in IL-12-treated T cells lacking
STAT4 after the first few rounds of cell
division. It was also shown that retroviral
overexpression of T-bet in STAT4-defi-
cient T cells that were activated in Th2-
cell-inducing conditions led to expression
of endogenous T-bet. This was inter-
preted as evidence for a T-bet autoactiva-
tion pathway and as an argument for
a symmetrical model of Th1 versus Th2
cell development. In this model, both
sides were induced by the cytokine they
generated: IFN-g induced T-bet and Th1
cell differentiation, and IL-4 induced
GATA3 and Th2 differentiation. Both line-
ages were stabilized by a transcriptional
autoactivation pathway involving their
master transcription factor.
An alternative interpretation that was
not excluded by this earlier study was
that the induction of endogenous T-bet
was secondary to IFN-g induced by re-
trovirally expressed T-bet. This would
be analogous to how IL-4 (induced by
retroviral GATA-3) might have acted on
cells to induce endogenous GATA3.
Secreted IFN-g, rather than IL-12, might
be the actual trigger for T-bet expression.
Indeed, a subsequent study of T-bet regu-
lation (Afkarian et al., 2002) tested this
possibility by looking at the induction of
endogenous T-bet under various circum-
stances. That study found that IFN-g
and activated STAT1 were both strong
activators of T-bet expression. Further-
more, retroviral T-bet was not able to
induce endogenous T-bet under con-
ditions where extracellular IFN-g was
neutralized or in the absence of STAT1,
arguing for an exogenous route of T-bet
induction rather than cell-intrinsic tran-
scriptional autoactivation. This interpreta-
tion suggested an asymmetric model of
Th1 cell versus Th2 cell development,
whereby Th2 cells used GATA3 autoacti-
vation but Th1 cells relied on extracellularsevier Inc.cues for regulation of T-bet. Again, as
other issues, such as the discovery of
additional T helper cell subsets (Harring-
ton et al., 2005), took greater importance,
the ideal system of a T-bet reporter
system to resolve these issues never
materialized.
The study by Zhu and colleagues in
this issue of Immunity has generated
a reporter for T-bet expression, by target-
ing GFP into the T-bet locus and
producing a BAC transgenic line carrying
this reporter. This study first carefully
documents the faithful expression of the
reporter as a surrogate for endogenous
T-bet, as is usually required when BACs
rather than a straight-up gene targeting
strategy are used. Passing this hurdle,
the study systematically examines the
question of which cytokine, IL-12 or
IFN-g, is responsible for the induction of
T-bet. Based on the examination of mice
lacking STAT4 and the receptor for
IFN-g, the answer is both, showing a clear
case of redundancy in the induction of
T-bet by Th1-cell-associated cytokines.
Moreover, the study readdresses the
issue of autoactivation. For one thing,
the study shows that T-bet is not required
for its own expression because the
reporter was induced similarly on either
wild-type or T-bet-deficient backgrounds
either when T cells were activated in vitro
under Th1-cell-polarizing conditions or
in vivo in the setting of infection with Toxo-
plasma gondii. However, the study does
not exclude totally some role for T-bet in
regulating its own expression; it did not
directly re-examine the conditions of
retroviral T-bet expression under Th2-
cell-polarizing conditions, which were
previously used for the conclusion or
exclusion of autoactivation. Nonetheless,
the system now provides this test with
the ideal reagent, which might be the
reporter crossed to the T-bet-deficient
background infected with T-bet-express-
ing retrovirus.
The study also provided findings
related to the interactions of T-bet with
the circuitry controlling T cell differentia-
tion. Glimcher and colleagues reported
several years ago that T-bet appeared
to directly interact with GATA3 (Hwang
et al., 2005) and that this interaction
mediated the direct repression of Th2
cell commitment. This is now evident in
the present study by the direct examina-
tion of ‘‘Th1 cell wannabes,’’ or more
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Figure 1. Reporting T-bet’s Expression
The production of a GFP reporter mouse for the ‘master’ transcription factor T-bet allows for clearer
separation in analysis of T-bet expression and its actions on IFN-g production. Results based on this
reporter imply that the stabilization of Th1 cells and that of Th2 cells might operate by somewhat
different circuitry. T-bet might not necessarily feed back on its own expression in the same manner as
that exhibited by GATA3, which can first be induced by IL-4, CD28 costimulation, or Notch signaling,
but which then acts to stabilize its own expression. For induction of Th1 cells, IL-12 or IFN-g can induce
the expression of T-bet through STAT4 or STAT1, respectively. Furthermore, STAT4 synergizes with T-bet
for downstream targets of Th1 cell development (such as the Ifng locus, not pictured). In addition, the
findings confirm a previously reportedmechanismwhereby T-bet might directly repress the Th2 cell differ-
entiation program—perhaps through direct interactions with GATA3—and confirm that T-bet and STAT4
cooperatively regulate Th1 cell-related genes, rather than acting one before the other in a strictly linear
model.
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in which the T-bet reporter is active under
the influence of Th1-cell-inducing condi-
tions. RNA-Seq and ChIP-Seq analyses
demonstrate that T-bet exerts both posi-
tive and negative transcriptional actions
in a cell-intrinsic manner. Importantly,
T-bet is shown to repress expression of
Th2-related genes, consistent with the
earlier finding that T-bet directly interacts
with GATA3 to block its activity. Anotherfinding from the study is that STAT4
acts synergistically with T-bet for the
production of IFN-g, as opposed to play-
ing a downstream role in a more linear
model of Th1 differentiation, as proposed
earlier (Figure 1).
Thus, although the current study does
not answer all of the previously unre-
solved questions, it does address some
important issues. Perhaps most impor-
tantly, the pilot light of this field seemsImmunity 37to have been relit after a period of
darkness. Fortunately, this new T-bet
GFP reporter strain is now being intro-
duced at a time that is much better suited
for analysis of Th cell subsets, given
that the intervening period has seen the
discovery and analysis of several addi-
tional subsets, as this study itself has
begun to address.
REFERENCES
Afkarian, M., Sedy, J.R., Yang, J., Jacobson, N.G.,
Cereb, N., Yang, S.Y., Murphy, T.L., and Murphy,
K.M. (2002). Nat. Immunol. 3, 549–557.
Harrington, L.E., Hatton, R.D., Mangan, P.R.,
Turner, H., Murphy, T.L., Murphy, K.M., and
Weaver, C.T. (2005). Nat. Immunol. 6, 1123–1132.
Hsieh, C.S., Macatonia, S.E., Tripp, C.S., Wolf,
S.F., O’Garra, A., and Murphy, K.M. (1993).
Science 260, 547–549.
Hwang, E.S., Szabo, S.J., Schwartzberg, P.L., and
Glimcher, L.H. (2005). Science 307, 430–433.
Kaplan, M.H., Sun, Y.L., Hoey, T., and Grusby,
M.J. (1996). Nature 382, 174–177.
Zhu, J., Jankovic, D., Oler, A.J., Wei, G., Sharma,
S., Hu, G., Guo, L., Yagi, R., Yamane, H.,
Punkosdy, G., et al. (2012). Immunity 37, this issue,
660–673.
Mullen, A.C., High, F.A., Hutchins, A.S., Lee, H.W.,
Villarino, A.V., Livingston, D.M., Kung, A.L., Cereb,
N., Yao, T.P., Yang, S.Y., and Reiner, S.L. (2001).
Science 292, 1907–1910.
Ouyang, W., Lo¨hning, M., Gao, Z., Assenmacher,
M., Ranganath, S., Radbruch, A., and Murphy,
K.M. (2000). Immunity 12, 27–37.
Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X.K.,
Fathman, C.G., and Glimcher, L.H. (2000). Cell
100, 655–669.
Zheng, W., and Flavell, R.A. (1997). Cell 89,
587–596., October 19, 2012 ª2012 Elsevier Inc. 593
